Daytime sleep in Parkinson's disease measured by episodes of immobility

Parkinsonism & Related Disorders - Tập 20 - Trang 578-583 - 2014
K. Kotschet1,2, W. Johnson2, S. McGregor2, J. Kettlewell1, A. Kyoong2, D.M. O'Driscoll3,4, A.R. Turton5, R.I. Griffiths1, M.K. Horne1,2
1Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville 3010, Australia
2St Vincent's Hospital, Fitzroy, Victoria 3065, Australia
3Department of Respiratory and Sleep Medicine, Eastern Health, Victoria 3128, Australia
4Southern Clinical School, Monash University, Clayton, Victoria 3168, Australia
5Monash Lung and Sleep, Monash Health, Clayton, Victoria 3168, Australia

Tài liệu tham khảo

Tan, 2002, Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls, Neurology, 58, 465, 10.1212/WNL.58.3.465 Lees, 1988, The nighttime problems of Parkinson's disease, Clin Neuropharmacol, 11, 512, 10.1097/00002826-198812000-00004 Ondo, 2001, Daytime sleepiness and other sleep disorders in Parkinson's disease, Neurology, 57, 1392, 10.1212/WNL.57.8.1392 Arnulf, 2009, Sleepiness in Parkinson's disease, Parkinsonism Relat Disord, 15, S101, 10.1016/S1353-8020(09)70792-8 Arnulf, 2005, Excessive daytime sleepiness in parkinsonism, Sleep Med Rev, 9, 185, 10.1016/j.smrv.2005.01.001 Johns, 2000, Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard, J Sleep Res, 9, 5, 10.1046/j.1365-2869.2000.00177.x Johns, 1991, A new method for measuring daytime sleepiness: the Epworth sleepiness scale, Sleep, 14, 540, 10.1093/sleep/14.6.540 Bliwise, 2012, Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class, Mov Disord, 27, 1118, 10.1002/mds.25082 Frucht, 1999, Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole, Neurology, 52, 1908, 10.1212/WNL.52.9.1908 Ferreira, 2001, Levodopa monotherapy can induce “sleep attacks” in Parkinson's disease patients, J Neurol, 248, 426 Pal, 2001, A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy, J Neural Transm, 108, 71, 10.1007/s007020170098 Olanow, 2000, Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole, Neurology, 54, 274, 10.1212/WNL.54.1.274 Gasser, 1992, Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease, Arch Neurol, 49, 1131, 10.1001/archneur.1992.00530350045017 Razmy, 2004, Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists, Arch Neurol, 61, 97, 10.1001/archneur.61.1.97 Poryazova, 2010, Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants, Eur Neurol, 63, 129, 10.1159/000276402 Hobson, 2002, Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group, J Am Med Assoc, 287, 455, 10.1001/jama.287.4.455 Rye, 2000, Daytime sleepiness in Parkinson's disease, J Sleep Res, 9, 63, 10.1046/j.1365-2869.2000.00201.x Arnulf, 2002, Parkinson's disease and sleepiness: an integral part of PD, Neurology, 58, 1019, 10.1212/WNL.58.7.1019 Valko, 2010, Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment, Eur J Neurol Off J Eur Fed Neurol Soc, 17, 1428 Arnulf, 2000, Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis, Neurology, 55, 281, 10.1212/WNL.55.2.281 Merino-Andreu, 2003, Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness, Neurology, 60, 1553, 10.1212/01.WNL.0000058905.71369.97 Shpirer, 2006, Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study, Mov Disord, 21, 1432, 10.1002/mds.21002 Stavitsky, 2010, Sleep in Parkinson's disease: a comparison of actigraphy and subjective measures, Parkinsonism Relat Disord, 16, 280, 10.1016/j.parkreldis.2010.02.001 Griffiths, 2012, Automated assessment of bradykinesia and dyskinesia in Parkinson's disease, J Parkinsons Dis, 2, 47 Jean-Louis, 1999, Actigraphic assessment of sleep in insomnia: application of the Actigraph Data Analysis Software (ADAS), Physiol Behavior, 65, 659, 10.1016/S0031-9384(98)00213-3 Australian Sleep Association, 2010 Frucht, 2000, Sleep episodes in Parkinson's disease: a wake-up call, Mov Disord, 15, 601, 10.1002/1531-8257(200007)15:4<601::AID-MDS1003>3.0.CO;2-Q Rye, 2002, Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD, Neurology, 58, 341, 10.1212/WNL.58.3.341 Rye, 2004, The two faces of Eve: dopamine's modulation of wakefulness and sleep, Neurology, 63, S2, 10.1212/WNL.63.8_suppl_3.S2 Monti, 2008, The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking, Prog Brain Res, 172, 625, 10.1016/S0079-6123(08)00929-1 Wienecke, 2012, Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?, J Sleep Res, 21, 710, 10.1111/j.1365-2869.2012.01027.x Bliwise, 2013, Daytime REM sleep in Parkinson's disease, Parkinsonism Relat Disord, 19, 101, 10.1016/j.parkreldis.2012.08.003 Iranzo, 2011, Sleep-wake changes in the premotor stage of Parkinson disease, J Neurol Sci, 310, 283, 10.1016/j.jns.2011.07.049 Li, 2005, Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons, J Neurosci, 25, 173, 10.1523/JNEUROSCI.4015-04.2005